Loading data
USBCNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | — | — | 0 USD | 4.36 m USD |
| Research and development expense | 1.75 m USD | 6.11 m USD | 7.73 m USD | 5.39 m USD |
| Selling, general and administrative expense | 16.29 m USD | 9.11 m USD | 6.57 m USD | 8.12 m USD |
| Operating profit | -18.05 m USD | -15.22 m USD | -14.02 m USD | -12.57 m USD |
| Interest expense | 1.19 m USD | 830.95 k USD | 389.63 k USD | 8.03 m USD |
| Profit before tax | -22.3 m USD | -16.58 m USD | -15.29 m USD | -20.07 m USD |
| Income tax expense | -172.84 k USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -22.12 m USD | -16.58 m USD | -15.29 m USD | -20.07 m USD |
| Diluted earnings per share | -0.39 USD/share | -7.85 USD/share | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.